Long-Term Adherence to Onabotulinum Toxin-A Intradetrusor Injections for Neurogenic Dysfunction in Children—A Retrospective Single-Center Evaluation

Onabotulinum Toxin-A (BTX-A) is a second-line treatment for neurogenic bladder (NB). It requires repeated injections over time, which is a possible limit for long-term adherence, especially in children, as general anesthesia is required. Almost 50% of adults discontinue therapy; few data on pediatri...

Full description

Bibliographic Details

Published in:	Toxins
Main Authors:	Chiara Pellegrino, Valentina Forlini, Maria Luisa Capitanucci, Gessica Della Bella, Giovanni Mosiello
Format:	Article
Language:	English
Published:	MDPI AG 2024-07-01
Subjects:	botulinum toxin-A neurogenic bladder pediatric neurotoxin neurogenic lower urinary tract dysfunction pediatric urology
Online Access:	https://www.mdpi.com/2072-6651/16/7/303